Patents by Inventor Kimberley Caroline Glennon

Kimberley Caroline Glennon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compounds
    Patent number: 7129253
    Abstract: Compounds of formula (I) wherein R1, R2, R3, R4, R5, R6, R7, R8, A, D, X, Y and Z have the meaning as defined in the claims exhibit protein tyrosine kinase and protein serin/threonine kinase inhibitory activity.
    Type: Grant
    Filed: December 19, 2003
    Date of Patent: October 31, 2006
    Assignee: SmithKline Beecham Corporation
    Inventors: Kimberley Caroline Glennon, Lee Frederick Kuyper, Karen Elizabeth Lackey, Robert Walton McNutt, Jr.
  • 3-(anilinomethylene)oxindoles
    Patent number: 6818632
    Abstract: Compounds of formula (I), wherein R1, R2, R3, R4, R5, R6, R7, R8, A, D, X, Y and Z have the meaning as defined in the claims, exhibit protein tyrosine kinase and protein serin/threonine kinase inhibitory activity.
    Type: Grant
    Filed: September 27, 2001
    Date of Patent: November 16, 2004
    Assignee: SmithKline Beecham Corporation
    Inventors: Kimberley Caroline Glennon, Karen Elizabeth Lackey
  • Compounds
    Publication number: 20040191210
    Abstract: 1
    Type: Application
    Filed: December 19, 2003
    Publication date: September 30, 2004
    Inventors: Kimberley Caroline Glennon, Lee Frederick Kuyper, Karen Elizabeth Lackey, Robert Walton McNutt
  • 3-(Anilinomethylene)oxindoles
    Publication number: 20020099071
    Abstract: 1
    Type: Application
    Filed: September 27, 2001
    Publication date: July 25, 2002
    Inventors: Kimberley Caroline Glennon, Lee Frederick Kuyper, Karen Elizabeth Lackey, Robert Walton McNutt
  • 3-(anilinomethylene) oxindoles
    Patent number: 6350747
    Abstract: The present invention relates generally to novel amine substituted oxindole compounds and compositions. Such compounds and compositions have utility as pharmacological agents in treating diseases or conditions alleviated by the inhibition or antagonism of protein kinase activated signalling pathways in general, and in particular in the pathological processes which involve aberrant cellular proliferation, such as tumor growth. In particular, the present invention relates to a series of substituted oxindole compounds, which exhibit protein tyrosine kinase and protein serine/threonine kinase inhibition, and which are useful in inhibiting tumor growth via inhibition of tumor-related angiogenesis.
    Type: Grant
    Filed: February 28, 2000
    Date of Patent: February 26, 2002
    Assignee: Glaxo Wellcome Inc.
    Inventors: Kimberley Caroline Glennon, Lee Frederick Kuyper, Karen Elizabeth Lackey, Robert Walton Mcnutt, Jr.